<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03940846</url>
  </required_header>
  <id_info>
    <org_study_id>LHist</org_study_id>
    <nct_id>NCT03940846</nct_id>
  </id_info>
  <brief_title>CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology</brief_title>
  <official_title>CT-based Radiomic Signature Can Identify Adenocarcinoma Lung Tumor Histology</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Maastricht University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of California, San Francisco</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Radboud University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maastricht University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Lung cancer remains the leading cause of cancer related mortality worldwide, with more than
      1.5 million related deaths annually. Lung cancer is divided into two main groups: Small Cell
      Lung Carcinoma (SCLC) and Non-Small Cell Lung Carcinoma (NSCLC), with prevalence of ~20% and
      80% respectively. NSCLC is further subdivided into adenocarcinoma (the most common), squamous
      cell carcinoma (SCC), and large cell carcinoma. Furthermore, each subtype is likely to have
      specific mutations, which could be targeted for treatment.

      Medical imaging and radiomics feature extraction represent a candidate alternative to
      conventional tissue biopsy, a theory that is investigated in this study.
    </textblock>
  </brief_summary>
  <overall_status>Active, not recruiting</overall_status>
  <start_date type="Actual">March 1, 2019</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 31, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lung histology</measure>
    <time_frame>December 2019</time_frame>
    <description>Is the tumor under investigation an adenocarcinoma of the lung?</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">650</enrollment>
  <condition>Nonsmall Cell Lung Cancer</condition>
  <arm_group>
    <arm_group_label>Maastro (Lung1)</arm_group_label>
    <description>Open source dataset available at TCIA.org. The cohort includes CT scans of 422 patients diagnosed with NSCLC.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>UCSF</arm_group_label>
    <description>A cohort of patients diagnosed with NSCLC at UCSF medical center. It includes CT scans of 165 patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Radboud</arm_group_label>
    <description>A cohort of patients diagnosed with NSCLC at Radboud medical center. It includes CT scans of 255 patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Stanford</arm_group_label>
    <description>Open source dataset available at TCIA.org. The cohort includes CT scans of 211 patients diagnosed with NSCLC.</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Virtual biopsy</intervention_name>
    <description>Radiomics -the high throughput extraction of quantitative features from medical imaging- extract features that might potentially decode biologic tumor information, which might ultimately reduce the need to use invasive procedure, such as tissue biopsy.</description>
    <arm_group_label>Maastro (Lung1)</arm_group_label>
    <arm_group_label>Radboud</arm_group_label>
    <arm_group_label>Stanford</arm_group_label>
    <arm_group_label>UCSF</arm_group_label>
    <other_name>Radiomics-based histology prediction</other_name>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with NSCLC, who further underwent tissue biopsy to determine tumor
        histology.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Availability of diagnostic non-contrast enhanced CT scan.

          -  Availability of histologic tumor analysis results

        Exclusion Criteria:

        -
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Maastricht University</name>
      <address>
        <city>Maastricht</city>
        <state>Limburg</state>
        <zip>6229ER</zip>
        <country>Netherlands</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Netherlands</country>
  </location_countries>
  <verification_date>April 2019</verification_date>
  <study_first_submitted>May 6, 2019</study_first_submitted>
  <study_first_submitted_qc>May 6, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">May 7, 2019</study_first_posted>
  <last_update_submitted>April 3, 2020</last_update_submitted>
  <last_update_submitted_qc>April 3, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 6, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Adenocarcinoma</mesh_term>
    <mesh_term>Carcinoma, Non-Small-Cell Lung</mesh_term>
    <mesh_term>Adenocarcinoma of Lung</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

